4507.T
Shionogi & Co.,Ltd.
プライム · 医薬品 · 医薬品 · JP
JPY 2,992.00
+0.34%Year over year
Reported trailing growth
- Revenue
- +14.0%
- EBITDA
- —
- EBIT
- +6.5%
- EPS
- -11.5%
- Free cash flow
- +11.6%
- Operating cash flow
- +9.3%
Forward estimates
Based on analyst estimates
- Revenue
- +0.1%
- EBITDA
- —
- EPS
- -8.4%
Three-year CAGR
- Revenue
- +5.4%
- EBITDA
- +5.2%
- EBIT
- +3.8%
- Net income
- +3.5%
- EPS
- -27.1%
- Free cash flow
- +6.2%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026